Thanks for visiting our PEGS US virtual stand
Whether you want to explore our wide range of services or learn more about RoukenBio, you're in the right place.
Download our Scientific Resources to discover what it's like working with the Immunology CRO redefined.
Enter now for your chance to win by filling out the short form via the button.

Explore RoukenBio's diverse in vitro assay services
Using our immuno-oncology expertise, we have developed an array of in vitro assay systems that aim to replicate the complex immune cell interactions in the TME as accurately as possible. With a strong focus on novel and emerging therapeutic classes that are designed to modulate these processes, our assay platforms are applicable to immuno-oncology, auto-immunity, inflammation and beyond.
Simply click on your selected flyers to access them:
RoukenBio - CRO redefined
Backed by our brilliant minds, we have turned the traditional CRO model on its head by fostering a collaborative and personalised approach.
Our mission is simple: Solve problems. Deliver quality data. Propel your drug discovery breakthroughs.
United by a passion to make sense of complexities and overcome challenges, we apply our specialised knowledge to big-picture thinking. We will explore every option to deliver over and above for your project.
We are thought leaders with a deep understanding of immunology, bioassays, molecular biology and a track record of groundbreaking discoveries and novel cell-based tools.
Learn from our research posters
1. A Targeted Integration System for the Efficient Creation of Isogenic Mammalian Cell Lines | Presented by Lewis Campbell
2. Target density matters - Binding kinetics of antibody-based therapeutics are highly influenced by target expression levels | Presented by Holly Greggan
3. Development of a high-throughput multimodal patient-derived platform integrating autologous fibroblasts and tumour-infiltrating lymphocytes for colorectal cancer drug discovery | Presented by Dr Alison Kerr



















